Fear of catching Covid higher in diabetics, says study

Delhi: A new study released by UK-based market research firm Kantar found that 60 per cent of the diabetics surveyed showed higher concern about catching Covid and getting hospitalised for the disease. The study titled ‘The D-Picture: Covid Edition’ covered 300 Type 2 diabetes patients across 12 cities, with all respondents belonging to the upper socio-economic class. ....read more

Natural anticoagulants

Natural anticoagulants for a healthy heart. Join us today at 7:00 PM ON MEDtalks with Dr K K Aggarwal for an in-depth discussion on anticoagulants.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

CMAAO Coronavirus Facts and Myth Buster: SNG001 Recombinant Interferon Beta

With input from Dr Monica Vasudev 1148: SNG001 recombinant interferon beta for inhaled delivery in COVID-19Interferons represent a group of signaling proteins which are made and released by host cells in response to the presence of several viruses. A virus-infected cell releases interferons which causes the nearby cells to escalate their anti-viral defenses. IFNs belong to the large class of proteins, termed cytokines, which are used for communication between cells to incite the protective defenses of the immune system that help eliminate the pathogens. ....read more

World COVID Meter 19th November: Acute manageable immunogenic thrombogenic inflammatory viral disease pandemic

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3, 27M September 7, 28M September 10, 29M September 14, 30M September 18, 31M September 21, 32M September 23, 33M September 28, 34M October 1, 35M October 4, 36M October 8, 37M October 11, 38M October 14, 39M October 17, 40M October 19, 41M October 22, 42M October 24, 43M October 26, 44M October 28, 45M October 30, 46M November 2, 47M November 4, 48M November 6, 49M November 7, 50M November 8, 51M November 10, 52M November 12, 53M November 14, 54M November 15, 55M November 17, 56M November 19 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 56,552,893,Deaths: 1,354,467,Recovered: 39,346,726,ACTIVE CASES 15,851,700,Currently Infected Patients 15,750,235 (99%) in Mild....read more

An empty mind is the devil’s house

It is an old saying that "Khali dimag shaitan ka ghar". Empty mind means when you are doing nothing and Shaitan means negative thoughts. In terms of Vedic science, negative thoughts mean absence of positive thoughts and they are often equated to darkness, which is absence of light. Positive thoughts always need efforts and exertions, while negative thoughts are spontaneous and without exertion. It is recommended that one should think differently and positive otherwise there will be spontaneous appearance of negative thoughts. ....read more

Video of The day

Implications of fatty liver, obesity and alcohol consumption in COVID-19

Healthcare News Monitor

USFDA Approved Foundation Medicine’s FoundationOne®Liquid CDx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India

microbiozindia.com

Mumbai, 18 November 2020: Roche Products (India) Pvt. Ltd. (Roche Pharma India) announces the launch of FoundationOne®Liquid CDx, Foundation Medicine’s comprehensive pan-tumor liquid biopsy test for patients with solid tumors in India. US FDA approved the FoundationOne®Liquid CDx, a comprehensive genomic profiling (CGP) test on August 26. This is the first test that can analyze more than 300 genes and multiple genomic signatures to optimize patient care. Cancer is a disease of the genome. Most tumors harbor a constellation of genomic alterations that may dictate their clinical behavior and treatment response. Blood-based biomarker testing options like FoundationOne®Liquid CDx can help expand access to genomic insights in patients with advanced cancer as compared to a tissue biopsy, which may not be an option for many patients due to reasons such as tumor location and patient’s health status. FoundationOne®Liquid CDx is a single non-invasive test based on Next Generation Sequencing technology that gives access to genomic information of over 300 genes. Additionally, the report also provides information about the biomarker signatures microsatellite instability (MSI), and blood tumor mutational burden (bTMB) to support informed decision making for targeted and immunotherapies.

WHO warns against remdesivir for Covid-19 treatment

health.economictimes

Geneva: The World Health Organization (WHO) on Friday warned that the antiviral drug remdesivir should not be used to treat Covid-19 patients no matter how ill they are as there is no evidence it works. "The panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others," Xinhua news agency quoted the WHOs Guideline Development Group (GDG) panel ass aying in a sattement.

India brings 50,000 Ayushman Bharat centres into operation during pandemic

livemint.com

Amidst the challenges posed by the covid-19 pandemic, India managed to make functional more than 50,000 (50,025) Ayushman Bharat - Health and Wellness Centres (AB-HWCs) across the country. With the aim of providing comprehensive primary health care (CPHC) services to the communities closer to their homes, 1.5 lakh AB-HWCs will be established by December 2022, the Union health ministry said on Friday. “With more than 50,000 [CENTRES] having been established, one third of the target has been met. This has led to improved access to affordable primary healthcare services for more than 25 crore people," said Harsh Vardhan, Union minister of health and family welfare.

Reimagining the next era of doctor engagement

tribuneindia.com

The COVID-19 pandemic has significantly altered the way doctors engage with their patients, and in turn, in the way that pharma companies approach doctors. The growth in remote healthcare in the past few months coupled with the fact that normalcy is unlikely to be restored anytime soon will require new engagement models by pharma companies to cater to the current paradigm. While the virtualisation of healthcare has been underway for some time, the pandemic has proven to be a tipping point. According to a recent Accenture doctor-patient research which surveyed 120 doctors and 700 patients in India, as patients avoided healthcare facilities, 73 per cent of them said that they learned new ways of managing their condition and communicating with their healthcare providers during COVID-19. The survey also found that the doctor community has embraced virtual tools such as online chat, telephone and video conference to better manage healthcare outcomes for their patients. While patients appreciated the virtual interactions and the convenience of being able to manage and monitor their care from home, they also felt that the quality of care declined due to reduced access to healthcare providers.